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Abstract  39 
Current understanding of cell specification in early mammalian preimplantation development is 40 
mainly based on mouse studies. The first lineage differentiation event occurs at the morula stage 41 
with outer cells initiating a trophectoderm (TE) program to become the earliest placental 42 
progenitors. At subsequent developmental stages, the inner cell mass (ICM) arises from inner 43 
cells and is comprised of precursor cells of the embryo proper and yolk sac1. Notably, recent 44 
gene expression analyses suggest that the mechanisms regulating early lineage specification in 45 
the mouse may differ in other mammals, including human2-5 and cow6,7. Here, we examined 46 
evolutionary conservation of cell dynamics and a molecular cascade initiating TE segregation in 47 
mouse, cow and human embryos using a comparative embryology approach. We discovered 48 
that the expression pattern of key TE lineage-associated factors shows a high degree of 49 
conservation among all three species. Specifically, at the morula stage outer cells acquire an 50 
apico-basal cell polarity, with expression of aPKC and PARD6B at the surface-free domain, 51 
nuclear expression of the Hippo signaling pathway effectors, YAP1 and WWTR1, and restricted 52 
expression of the transcription factor GATA3, suggesting initiation of a TE program. Furthermore, 53 
we demonstrate that inhibition of aPKC, by small-molecule pharmacological modulation and 54 
TRIM-Away protein depletion, impairs TE initiation at the morula stage. Altogether, our 55 
comparative embryology analysis provides novel insights into early lineage specification in 56 
human preimplantation embryos and suggests a similar mechanism initiating a TE program in 57 
mouse, cow and human embryos. 58 
 59 
Main text 60 
Our current understanding of cell specification during mammalian preimplantation development 61 
mainly relies on mouse studies. At the 8-cell stage, the mouse embryo undergoes a drastic 62 
morphological change, where blastomeres flatten and adhere to each other in a process known 63 
as compaction8. After subsequent rounds of cell division two distinct cell populations are 64 
discernible at the morula stage: inner and outer cells. Following this, a blastocyst is formed, 65 
whereby the inner cells give rise to the inner cell mass (ICM), and the outer cells become the 66 
trophectoderm (TE), a polarized epithelium that will form fetal components of the placenta. 67 
Subsequently, the ICM will further segregate into the epiblast (EPI), which gives rise to the fetus, 68 
and the primitive endoderm (PrE), which primarily contributes to the yolk sac1. 69 
 70 
Concomitant with compaction, cell polarity is established in the 8-cell mouse embryo. Inner and 71 
outer cells display different polarization states, which influence their cell fate acquisition. The 72 
contact-free surface of the outer cells acquires an apical domain, enriched with the Atypical 73 
protein kinase C (aPKC) that together with the proteins Partitioning defective homolog 6B 74 
(PARD6B) and homolog 3 (PARD3), forms the anterior PAR polarity complex, while PAR1 75 
(EMK1 or MARK2), E-CADHERIN and other cell adhesion molecules localize to the basolateral 76 
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domain9-12. In the polar outer cells, the apical PAR proteins sequester Angiomotin (AMOT), a 77 
modulator of the Hippo pathway, from the junctional complexes. This interaction prevents 78 
activation of downstream Hippo pathway kinases, Large tumor suppressor kinases 1/2 79 
(LATS1/2)13. Consequently, in outer cells, Yes-associated protein 1 (YAP1) and WW domain-80 
containing transcription regulator protein 1 (WWTR1, also known as TAZ) accumulate in the 81 
nucleus where, together with TEA-domain family member 4 (TEAD4), they promote the 82 
expression of TE lineage-associated factors, such as Caudal type homeobox 2 (Cdx2) and Gata 83 
binding protein 3 (Gata3)14-16. By contrast, in the apolar inner cells, AMOT is free to interact with 84 
a large protein complex at the cell junction and is activated through phosphorylation by LATS1/2. 85 
In these cells, activation of the Hippo pathway results in YAP1 and WWTR1 phosphorylation and 86 
cytoplasmic retention, thus maintaining the inner cells in an unspecified state13,17,18. 87 
 88 
In the mouse, CDX2 is expressed in outer cells from the morula stage and Cdx2 mutant embryos 89 
exhibit loss of epithelial integrity at the blastocyst stage, thus failing to maintain the blastocoel 90 
cavity or to implant14. Notably, in human, cow and pig embryos, CDX2 is detectable later in 91 
cavitating blastocysts2,6,7,19. A recent study in human embryos, using single-cell RNA-sequencing 92 
(scRNA-seq) analysis, suggests concurrent establishment of EPI, PrE and TE at the blastocyst 93 
stage5. These differences hint at a divergent molecular cascade controlling cell specification in 94 
mouse and other mammals. However, detailed protein expression and functional analyses of 95 
cow and human embryos are still missing. We hypothesize that, similar to the mouse20,21, the 96 
outer cells of cow and human embryos initiate a TE program at the morula stage to form a 97 
functional epithelium that drives and supports cavitation to form a blastocyst.  98 
To test this hypothesis, we combined morphokinetic analysis, molecular characterization and 99 
functional inhibition. We particularly focused our analysis at the morula stage, where the 100 
embryos are still a compacted group of cells without a single dominant cavity. Our results 101 
suggest a high degree of conservation of the molecular cascade initiating TE specification at the 102 
morula stage in mouse, cow and human embryos.  103 
 104 
First, we performed morphokinetic analysis of mouse, cow and human embryos (Movies 1-3). As 105 
the length of preimplantation embryogenesis varies between these three species, we calculated 106 
the duration of each developmental stage as a percentage of time from the 8-cell stage to the 107 
end of cavitation (Extended Data Fig. 1a). We observed that mouse embryos remain at the 8-108 
cell stage for a comparatively short period of time and rapidly undergo compaction. By contrast, 109 
we observed a prolonged 8-cell to compaction transition with multiple cell divisions in cow and 110 
human embryos (Extended Data Fig. 1b-f). We termed this stage “pre-compaction”. Mouse 111 
embryos exhibit a relatively long morula stage, while cow and in particular human embryos show 112 
a comparatively rapid transition between compaction and cavitation (Extended Data Fig. 1b-d 113 
and Extended Data Table 1). In addition, we quantified the number of inner and outer cells at 114 
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the morula stage and found that cow and mouse embryos have a similar percentage of inner 115 
cells, while human embryos show a strikingly reduced proportion of inner cells (Extended Data 116 
Fig. 1g). Similarly, we observed a difference in the number of ICM cells in mouse and cow 117 
compared to human blastocyst stage embryos (Extended Data Fig. 1h). These data suggest 118 
that the proportion of inner cells at the morula stage is indicative of the number of ICM cells 119 
found later in development and, moreover, that human blastocysts contain fewer cells fated to 120 
contribute to EPI and PrE. Taken together, this comparative morphokinetic analysis provides 121 
relevant information to consider when comparing similar developmental stages in different 122 
species. 123 
 124 
Since CDX2 is detectable in TE cells only at later stages in cow and human embryos2,6,14, we 125 
sought to determine whether alternative TE-associated genes may be expressed prior to 126 
blastocyst formation. We mined published human preimplantation scRNA-seq datasets4,5,22 and 127 
were intrigued to observe heterogeneous expression of GATA3 in human morula cells (Fig. 1a, b 128 
and Extended Data Fig. 2a). Moreover, we reanalyzed a human preimplantation chromatin 129 
accessibility dataset23 and performed differential analysis of putative transcription factor binding 130 
sites enriched in accessible regions between the morula and 8-cell stage. Interestingly, we 131 
identified enrichment of GATA and TEAD motifs at the morula stage, whereas at the 8-cell stage 132 
we observed motif enrichment of genes involved in embryonic genome activation, such as 133 
DUXA/DUX424 and ZSCAN425 (Fig. 1c). In the mouse, GATA3 expression overlaps with CDX2 in 134 
outer cells at the morula stage, and an elegant genetic analysis demonstrated that GATA3 acts 135 
downstream of TEAD4/YAP1 and in parallel to CDX215. The protein localization of TEAD4 and 136 
YAP1 is different between inner and outer cells, with TEAD4 detected in all nuclei, while YAP1 is 137 
localized only in the nuclei of outer cells26,27. By immunofluorescence analysis, we confirmed that 138 
TEAD4 shows a similar expression pattern in the human, with nuclear expression detected in all 139 
cells of morula stage embryos (Extended Data Fig. 3). Next, we analyzed the expression of 140 
YAP1 and GATA3 in mouse embryos and observed co-localized nuclear expression of these 141 
factors in outer cells at the morula stage, while in inner cells YAP1 is retained in the cytoplasm 142 
and GATA3 is absent, consistent with previous findings15,16 (Extended Data Fig. 2b-e). We 143 
observed nuclear YAP1 and GATA3 expression in cow and human embryos at late compaction 144 
and their expression was not detectable prior to compaction (Fig. 1g and Extended Data Fig. 2f 145 
and 4a). At the morula stage, outer cells show co-localized nuclear expression of YAP1 and 146 
GATA3, while inner cells do not have detectable expression (Fig. 1d-i and Extended Data Fig. 147 
4a). In expanded cow and human blastocysts, YAP1 and GATA3 expression is maintained in the 148 
nuclei of TE cells and is not detected in ICM cells (Fig. 1d, g and Extended Data Fig. 4a). 149 
Similar to the mouse16, we observed WWTR1 and YAP1 overlapping nuclear expression in outer 150 
and TE cells in human morula and blastocyst stages, respectively (Extended Data Fig. 5a, b). 151 
GATA2 is considered a TE marker in human blastocysts3-5,28. Importantly, at the morula stage 152 
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GATA2 is not detected (Extended Data Fig. 2g), despite its restriction to TE cells at the 153 
blastocyst stage (Extended Data Fig. 2h). By contrast, GATA3 is expressed at both morula and 154 
blastocyst stages in outer and in TE cells, respectively (Extended Data Fig. 2g, h), indicating 155 
that expression of GATA3, and not GATA2, at the morula stage may distinguish cells that are 156 
initiating a TE program. 157 
 158 
To find additional genes associated with TE initiation in human embryos, we initially identified 159 
genes that were co-expressed with GATA3 in TE cells at the blastocyst stage using the 160 
aforementioned scRNA-seq datasets4,5,22 and analyzed the expression of these genes earlier at 161 
the morula stage. Among these genes, 22 showed a positive correlation (Pearson’s r > 0.25) with 162 
GATA3 when comparing all human morula cells (Extended Data Table 2). Genes related to 163 
epithelial cell formation (KRT18, CLDN4, RAB20, RAB25), and placenta morphogenesis 164 
(PTGES, PLAC8) and genes encoding transporter subunits (ATP6V1B1, ATP6V1C2, FXYD4, 165 
ATP6V0A4, SLC7A2) positively correlate with GATA3 (Fig. 1k and Extended Data Fig. 6a-c, 8 166 
and Extended Data Table 3). Interestingly, we observed that Vestigial-like protein 4 (VGLL4), a 167 
transcriptional co-factor and regulator of TEAD transcriptional activity29, also shows a positive 168 
correlation with GATA3 (Extended Data Fig. 6d, 8 and Extended Data Table 3). 169 
Immunofluorescence analysis confirmed the specific expression of KRT18 in outer and TE cells 170 
in human morula and blastocyst stage embryos, respectively (Fig. 1j, Extended Data Fig. 4a 171 
and Extended Data Fig. 5c), as previously described30. Interestingly, the chromatin accessibility 172 
data indicates enrichment of GATA binding motifs at the KRT8 and KRT18 loci (Fig. 1l), 173 
suggesting that KRT8 and KRT18 may be candidate target genes of GATA3 in human embryos.  174 
In the positively correlated gene list, we also detected Grainyhead-like transcription factor 2 175 
(GRHL2) (Extended Data Fig. 6a, 8 and Extended Data Table 3), a gene important for 176 
epithelial morphogenesis and trophoblast branching in mouse embryos31,32. We also observed 177 
an enrichment of GATA binding motifs upstream the GRHL2 locus (Extended Data Fig. 5d). By 178 
immunofluorescence analysis, we observed that GRHL2 is expressed in both outer and inner 179 
cells at the morula stage (Extended Data Fig. 5e). Upon blastocyst expansion, GRHL2 is 180 
specifically expressed in TE cells and no longer present in ICM cells (Extended Data Fig. 5f). 181 
Next, we analyzed scRNA-seq datasets to identify genes that exhibited an anti-correlated 182 
expression pattern to GATA3 in human morula cells (Fig. 1a) and that could be putative inner 183 
cell-associated markers. Interestingly, genes involved in embryonic stem cell pluripotency and/or 184 
genes enriched in the EPI/ICM, such as DPPA333, KLF174,34 and ARGFX4,28,35 were 185 
transcriptionally negatively correlated with GATA3 (Fig. 2e-g, Extended Data Tables 4, 5 and 186 
Extended Data Fig. 7, 8). Altogether, our analysis of existing scRNA-seq data suggests 187 
transcriptional differences between inner and outer cells at the morula stage. 188 
 189 
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In the mouse morula, the transcription factor SOX2 is specifically restricted to inner cells and is 190 
considered the first marker of ICM pluripotency36,37 (Extended Data Fig. 9a, b). At the 8-cell 191 
stage, SOX2 was detected in a few blastomeres in cow embryos, while in human embryos SOX2 192 
was expressed in all nuclei (Fig. 2c, Extended Data Fig. 4b and 9c). In late compacting 193 
embryos, SOX2 was detected in all nuclei in both species (Fig. 2c, Extended Data Fig. 4b and 194 
9c). At the morula stage, when GATA3 begins to be differentially expressed between outer and 195 
inner cells, SOX2 remains expressed in all cells in human and cow embryos, in contrast to the 196 
mouse (Fig. 2a-d and Extended Data Fig. 4b and 9a, b). SOX2 becomes restricted to ICM cells 197 
only in expanded blastocysts (Fig. 2a, c and Extended Data Fig. 4b and 9d), thus confirming 198 
previously published data in human embryos30. Altogether, these data indicate that SOX2, the 199 
specific inner cell marker in the mouse, displays a different expression pattern in cow and human 200 
embryos, thus suggesting it may be regulated differently in these species. 201 
 202 
Since we observed expression of YAP1 and GATA3 specifically in the nuclei of outer cells at the 203 
morula stage in these three species, we next sought to investigate upstream regulators of this 204 
pathway in cow and human embryos. We analyzed the expression pattern of aPKC and AMOT, 205 
which influence YAP1 cellular localization in mouse outer cells13. We confirmed that in the mouse 206 
morula, aPKC and AMOT are expressed at the apical membrane of outer cells, while in inner 207 
cells AMOT and E-CADHERIN are enriched at the cell-cell contact sites (Fig. 3a, d, Extended 208 
Data Fig. 4c and 10a). We detected a similar expression pattern in cow morula stage embryos 209 
with aPKC and AMOT strongly co-localized at the apical domain of outer cells and β-CATENIN at 210 
the basolateral domain (Fig. 3b, e, Extended Data Fig. 4c and 10b). We identified expression of 211 
aPKC and AMOT at the apical domain of human morula stage embryos, which opposed β-212 
CATENIN and E-CADHERIN at the basolateral domain (Fig. 3c, f, Extended Data Fig. 4c and 213 
10c). Moreover, we could observe co-localization of aPKC and its partner, PARD6B, at the apical 214 
domain of cells in both human morula and blastocyst stage embryos (Extended Data Fig. 10d, 215 
e). These data reveal differential cell polarization between outer and inner cells in cow and 216 
human embryos, with apical and basolateral proteins showing a similar expression pattern to that 217 
of the mouse10,38.  218 
 219 
Our data suggest a possible functional link between cell polarity and TE lineage initiation at the 220 
morula stage in cow and human embryos. In order to test this hypothesis, we used a potent 221 
aPKC inhibitor, CRT0276121, a derivative of CRT0103390, which has previously been shown to 222 
specifically inhibit aPKC in various biological and cellular contexts39-41. Initially, we performed a 223 
dose-response experiment with treatment from the 4-cell stage to determine the effective 224 
concentration of aPKC inhibitor (Extended Data Fig. 11a, b and Extended Data Table 6). 225 
Following aPKC inhibition, we observed that YAP1 was restricted to the cytoplasm in outer cells 226 
(Extended Data Fig. 12a, b), consistent with previous descriptions in aPKC knockdown and 227 
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knockout studies9,13,42. We also observed that inhibition of aPKC led to reduced GATA3 228 
expression at the morula stage (Extended Data Fig. 12a, c), indicating that aPKC is required to 229 
initiate TE-associated gene expression in outer cells. Moreover, SOX2 was ectopically 230 
expressed in outer cells at the morula stage following aPKC inhibition in the mouse (Extended 231 
Data Fig. 13a-c). These data phenocopy the Yap1-/-;Wwtr1-/- phenotype and the effects of ROCK 232 
inhibition in mouse embryos18, thus indicating specificity of the aPKC inhibitor. In addition, in our 233 
morphokinetic analysis, we could not detect differences in cleavage rate between control and 234 
treated embryos (Extended Data Fig. 14a, b). In addition, while DMSO-treated control mouse 235 
embryos developed to the blastocyst stage, aPKC inhibitor-treated embryos failed to cavitate and 236 
underwent developmental arrest at the morula stage (Extended Data Fig. 14c, d), 237 
phenocopying aPKC null mutant embryos13,42.  238 
 239 
We next analyzed the effects of aPKC inhibition on cow and human embryos by treating from 240 
pre-compaction until the morula stage, following dose-response experiments (Extended Data 241 
Fig. 11c-f and Extended Data Tables 7, 8). Inhibition of aPKC in cow embryos resulted in 242 
reduction of nuclear YAP1 and GATA3 expression in outer cells at the morula stage (Fig. 4a-c). 243 
Similarly, human embryos at the morula stage exhibited reduced expression of YAP1 and 244 
GATA3 in outer cells following aPKC inhibition (Fig. 4d-f). Moreover, when both cow and human 245 
embryos were allowed to develop to the blastocyst stage, the DMSO-treated embryos were able 246 
to form expanded blastocysts, while a significant number of aPKC-inhibitor treated embryos 247 
arrested at cavitation (Extended Data Fig. 14e-h). Interestingly, in aPKC inhibitor-treated cow 248 
and human embryos, SOX2 expression was retained in all cells similar to control embryos 249 
(Extended Fig. 13d, e), which is in striking contrast to the mouse. As expected, TEAD4 250 
expression was unchanged in both mouse and human aPKC-inhibitor treated embryos 251 
(Extended Data Fig. 12d, e), thus further corroborating the specificity of the aPKC inhibitor.  252 
 253 
In order to further confirm our results, we sought to test our hypothesis applying TRIM-Away 254 
protein depletion method in embryos. TRIM-Away has been recently reported to induce rapid and 255 
efficient degradation of proteins of interest in mouse oocytes43. Firstly, we optimized 256 
electroporation of mCherry-TRIM21 mRNA with an antibody against aPKC in mouse embryos at 257 
the 4-cell stage (Extended Data Fig. 15 and Extended Table 9). Our analysis of mouse morula 258 
stage embryos showed that the expression of endogenous aPKC was reduced following 259 
mCherry-TRIM21 mRNA and aPKC antibody electroporation compared to the control embryos 260 
where only mCherry-TRIM21 mRNA was provided (Extended Data Fig. 16a, b). Moreover, we 261 
observed a reduction of YAP1 and GATA3 protein expression in embryos electroporated with 262 
mCherry-TRIM21 mRNA and aPKC antibody (Extended Data Fig. 16c-d). Electroporation of 4-263 
cell stage human embryos led to a similar reduction of YAP1 and GATA3 protein expression 264 
compared to control embryos (Fig. 4g-k), confirming the effect seen with the aPKC inhibitor. 265 
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Despite attempts to optimize electroporation in cow embryos, we were unable to identify a 266 
concentration of TRIM-Away components that affected YAP1 and GATA3 protein expression 267 
without affecting embryo viability (Extended Data Fig. 17 and Extended Table 10), suggesting 268 
that further refinement of the method is needed in this species. 269 
 270 
Altogether, these data provide novel insights into cow and human preimplantation development 271 
and TE specification. With protein expression, morphokinetic, transcriptomic and functional 272 
analyses, we propose that cell polarity, through aPKC activity, initiates a TE program at the 273 
morula stage in the outer cells of human and cow embryos (Fig. 4l), similar to the mouse9,13,42. 274 
We propose that in cow and human morula stage embryos, outer cells acquire cell polarization, 275 
which triggers a molecular cascade influencing cell fate. Our data suggest that similar to the 276 
mouse, in human and cow embryos, aPKC sequesters AMOT at the apical domain, thus keeping 277 
the Hippo signaling pathway in an inactive state. YAP1 subsequently translocates to the nucleus, 278 
where together with TEAD4, it promotes the transcriptional activation of a TE program. Additional 279 
molecular characterization is needed in human and cow embryos to elucidate how differences in 280 
cell polarity leads to differential Hippo signaling in outer and inner cells, and whether it involves 281 
mechanisms that are conserved or divergent compared to the mouse. We observed that GATA3 282 
is the earliest TE-associated transcription factor detected so far in human and cow morula stage 283 
embryos. It will be interesting to determine whether and how GATA3 drives this early human 284 
placental program.  285 
 286 
Besides compaction and cell polarization, another morphological change occurring during 287 
preimplantation development is cavitation. During this process, outer cells pump fluid into the 288 
embryo to form a blastocoel cavity, causing disruption of the radial symmetry of the embryo21. To 289 
support the formation of a cavity, outer cells assemble functional tight junctions, in order to form 290 
a seal and prevent fluid leakage1,21. Interestingly, our re-analysis of scRNA-seq datasets shows 291 
that genes involved in cell epithelialization and genes encoding transporter subunits are 292 
positively correlated with GATA3 expression in human morula cells. scRNA-seq datasets lack 293 
positional information of the cells collected, but our protein expression analysis shows that 294 
GATA3 is detected only in outer cells at the morula stage. In addition, re-analysis of chromatin 295 
accessibility profiles of the human morula stage allowed us to identify enrichment of GATA motifs 296 
near genes involved in cell epithelialization, such as KRT8, KRT18 and GRHL2. Therefore, we 297 
propose that in human preimplantation embryos, outer cells at the morula stage initiate a TE 298 
program in order to support cavitation and formation of a blastocyst (Fig. 4l). While our data 299 
reveal a molecular cascade that leads to the initiation of a TE program, cells are unlikely to be 300 
committed at this stage, which is supported by studies suggesting that cell fate determination 301 
occurs later5,44. 302 
 303 
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Interestingly, CDX2, a TE lineage-associated transcription factor that is detectable in the mouse 304 
morula, is expressed in human and cow embryos only at the blastocyst stage2,6. This suggests 305 
that despite a high degree of conservation in the link between cell polarity and initiation of a TE 306 
program, not all factors associated with an early TE gene regulatory network may be conserved 307 
across species. Consistently, by immunofluorescence analysis, we were not able to detect 308 
cytoplasmic retention of YAP1 in the inner cell population in cow and human morula, while we 309 
clearly detected this pattern in mouse embryos. This observation suggests a difference in the 310 
regulation of YAP1 in inner cells. It is unclear whether this relates to the different expression 311 
pattern we observed for SOX2 in the mouse compared to cow and human embryos. It has 312 
recently been shown that SOX2 is repressed by YAP1/WWTR1/TEAD4 in the inner cell 313 
population until LATS1/2 become expressed at the 16-cell stage18,45. It would be interesting to 314 
understand whether SOX2 expression is modulated by YAP1/WWTR1/TEAD4 in cow and 315 
human embryos at later stages when SOX2 is restricted to the ICM, or if it is regulated by 316 
alternative mechanisms. Additional functional analysis such as dominant negative mutations or 317 
CRISPR/Cas9-mediated genome editing will help to address these questions and to further 318 
understand the factors that function in parallel, downstream or upstream of YAP1 and GATA3 to 319 
drive a placental progenitor program. 320 
 321 
Data Availability 322 
The datasets analyzed during the current study were previously published and are available at 323 
the GEO repository GSE36552, at EMBL-EBI ArrayExpress: E-MTAB-3929 and at EMBL-EBI 324 
ENA: PRJNA494280.  325 
 326 
Code availability 327 
The data processing and analysis pipelines are publicly available at 328 
https://github.com/galanisl/TE_differentiation. 329 
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Fig. 1. Transcriptional and protein expression differences between cells at the morula 
stage in cow and human embryos. 
a, Violin plot showing log-transformed size-factor-normalized expression of GATA3 in human 
morula cells. n = 197 cells. Black line corresponds to the median. Highlighted in red are the 10% 
of the human morula cell samples with lowest levels of GATA3 expression and in blue are the 
members of the cluster with high levels of GATA3 expression in panel b. b, griph dimensionality 
reduction analysis of the human morula cells. Single cells have been colored with the log-
transformed size-factor-normalized expression of GATA3. c, ATAC-seq chromatin accessibility in  
human embryos at the morula stage compared to the 8-cell stage. Transcription factors with a 
significant change in activity score (p-value < 0.05) are highlighted in purple in the morula and in 
cyan in the 8-cell stage. d, Time-course immunofluorescence analysis of GATA3 (green), β-
CATENIN (red), YAP1 (magenta) and DAPI nuclear staining (blue) in cow embryos at different 
developmental stages: morula (n = 11) and expanded blastocyst (n = 5). e, f, Quantification of 
YAP1 (e) and GATA3 (f) fluorescence intensity, normalized to DAPI intensity, in either inner or 
outer cells in cow morula stage embryos (n = 97 cells from 11 embryos). t-test, ****p < 0.0001. g, 
Time-course immunofluorescence analysis of GATA3 (green), F-ACTIN (red), YAP1 (magenta) 
and HOECHST-33342 nuclear staining (blue) in human embryos at different developmental 
stages: pre-compaction (n = 5), late compaction (n = 5), morula (n = 10), expanded blastocyst (n 
= 4). h, i, Quantification of YAP1 (h) and GATA3 (i) fluorescence intensity, normalized to 
HOECHST-33342 intensity, in either inner or outer cells in human morula embryos (n = 95 cells 
for YAP1 and n = 79 for GATA3 from 10 embryos). t-test for YAP1 distribution, ****p < 0.0001; 
Mann-Whitney U test for GATA3 distribution, ****p < 0.0001. Yellow arrowheads point to outer 
cells expressing YAP1 and GATA3, while cyan arrows mark inner cells devoid of YAP1 and 
GATA3 expression. j, Immunofluorescence analysis of GATA3 (green), KRT18 (magenta) and 
DAPI nuclear staining (blue) in human morula stage embryos. n = 3. k, Scatter plots showing 
positive correlation of GATA3 expression profile with KRT18 expression profile in human morula 
cells. n = cells considered. r = Pearson correlation coefficient. Values are displayed as log-
transformed size-factor-normalized counts. The black line corresponds to a linear regression 
model fitted to the data with 95% confidence bands. l, Genome browser view of ATAC-seq signal 
at the KRT8 and KRT18 loci. High confidence peaks (FDR < 0.001) were used to identify 
transcription factor motifs. Representative binding motifs associated with the footprints are 
highlighted. Scale bars, as displayed in figures.  
 
Fig. 2. SOX2 is an inner cell-specific marker in mouse, but not in cow and human morula 
stage embryos. 
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a, Time-course immunofluorescence analysis of SOX2 (green), β-CATENIN (red), GATA3 
(magenta) and DAPI nuclear staining (blue) in cow embryos at different developmental stages: 
morula (n = 9) and expanded blastocyst (n = 5). b, Quantification of SOX2 fluorescence intensity, 
normalized to DAPI intensity, in either inner or outer cells in cow morula stage embryos (n = 136 
cells from 9 embryos). c, Time-course immunofluorescence analysis of SOX2 (green), β-
CATENIN (red), GATA3 (magenta) and DAPI nuclear staining (blue) in human embryos at 
different developmental stages: pre-compaction (n = 5), late compaction (n = 5), morula (n = 6), 
expanded blastocyst (n = 5). d, Quantification of SOX2 fluorescence intensity, normalized to 
DAPI intensity, in either inner or outer cells in human morula stage embryos (n = 68 cells from 6 
embryos). Yellow arrowheads point to outer cells expressing SOX2 and GATA3. t-test, ****p < 
0.0001, ns = not significant. e-g, Scatter plots showing negative correlation of GATA3 expression 
profile with DUXA (e), KLF17 (f) and DPPA3 (g) expression profiles in human morula cells. n = 
cells considered. r = Pearson correlation coefficient. Values are displayed as log-transformed 
size-factor-normalized counts. The black line corresponds to a linear regression model fitted to 
the data with 95% confidence bands. Scale bars, as displayed in figures.  
 
Fig. 3. Apical expression of aPKC and AMOT in outer cells in mouse, cow and human 
morula stage embryos. 
a, Immunofluorescence analysis of aPKC (green), E-CADHERIN (red), AMOT (magenta) and 
DAPI nuclear staining (blue) in mouse morula stage embryos (n = 10). b, Immunofluorescence 
analysis of aPKC (green), β-CATENIN (red), AMOT (magenta) and DAPI nuclear staining (blue) 
in cow morula stage embryos (n = 10). c, Immunofluorescence analysis of aPKC (green), β-
CATENIN (red), AMOT (magenta) and DAPI nuclear staining (blue) in human morula stage 
embryos (n = 10). d-f, Fluorescence intensity profile of aPKC and AMOT shown along the yellow 
arrows in mouse (d), cow (e) and human (f) morula stage embryos. Scale bars, as displayed in 
figures. 
 
Fig. 4. aPKC depletion leads to reduced nuclear YAP1 and GATA3 expression in outer 
cells in mouse, cow and human embryos. 
a, Immunofluorescence analysis of GATA3 (green), β-CATENIN (red), YAP1 (magenta) and 
DAPI nuclear staining (blue) in control and aPKC inhibitor-treated cow morula stage embryos. n 
= 3 biological experiments. b, c, Quantification of YAP1 (b) and GATA3 (c) fluorescence 
intensity, normalized to DAPI intensity, in outer cells in control and aPKC-inhibitor treated cow 
morula stage embryos (n = 209 cells for YAP1 from 19 embryos, and n = 218 cells for GATA3 
from 21 embryos). Mann-Whitney U test for YAP1 distribution, ****p < 0.0001. d, 
Immunofluorescence analysis of GATA3 (green), β-CATENIN (red), YAP1 (magenta) and DAPI 
nuclear staining (blue) in control and aPKC inhibitor-treated human morula stage embryos. n = 3 
biological experiments. e, f, Quantification of YAP1 (e) and GATA3 (f) fluorescence intensity, 
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normalized to DAPI intensity, in outer cells in control and aPKC-inhibitor treated human morula 
stage embryos (n = 406 cells for YAP1 from 37 embryos, and n = 218 cells for GATA3 from 21 
embryos). Mann-Whitney U test, ****p < 0.0001. g, Schematic of the TRIM-Away approach. h, 
Schematic representation of the TRIM-Away experiment. i, Immunofluorescence analysis of anti-
mouse secondary antibody (to detect the aPKC antibody electroporated in) (green), YAP1 (red), 
GATA3 (magenta) and DAPI nuclear staining (blue) at the morula stage in human control 
embryos and embryos electroporated with mCherry-TRIM21 mRNA and anti-aPKC antibody. 
Yellow arrowheads point to decrease YAP1 and GATA3 expression in the TRIM-Away 
experiment. n = 3 biological experiments. j, k, Quantification of YAP1 (j) and GATA3 (k) 
fluorescence intensity, normalized to DAPI intensity, in outer cells at the morula stage in human 
control embryos and embryos electroporated with mCherry-TRIM21 mRNA and anti-aPKC 
antibody (n = 91 cells from 8 embryos). Mann-Whitney U test, *p < 0.05, ****p < 0.0001. Scale 
bars as displayed in figures. l, Proposed model for human early lineage specification. EPI, 
epiblast; PrE, primitive endoderm; TE, trophectoderm. E-CAD, E-CADHERIN; β-CAT, β-
CATENIN. 
